Eun K. Cho

Holistic Medicine
3020 Wilshire Blvd, 222, 
Los Angeles, CA 
3020 Wilshire Blvd, 222, 
Los Angeles, CA 

Overview

Eun Cho is a Holistic Medicine provider in Los Angeles, California. Her top areas of expertise are Endoscopy and Colonoscopy.

Her clinical research consists of co-authoring 187 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Holistic Medicine

Licenses

Acupuncturist in CA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

3020 Wilshire Blvd, 222, Los Angeles, CA 90010

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II Single-arm Trial to Investigate Tepotinib in Advanced (Locally Advanced or Metastatic) Non-small Cell Lung Cancer With METex14 Skipping Alterations or MET Amplification (VISION)
A Phase II Single-arm Trial to Investigate Tepotinib in Advanced (Locally Advanced or Metastatic) Non-small Cell Lung Cancer With METex14 Skipping Alterations or MET Amplification (VISION)
Enrollment Status: Active_not_recruiting
Publish Date: December 23, 2025
Intervention Type: Drug
Study Drug: Tepotinib
Study Phase: Phase 2
LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy With or Without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy With or Without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drugs: Selpercatinib, Carboplatin, Cisplatin, Pemetrexed, Pembrolizumab
Study Phase: Phase 3
A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)
A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)
Enrollment Status: Completed
Publish Date: September 12, 2025
Intervention Type: Drug
Study Drugs: Brigatinib, Alectinib
Study Phase: Phase 3
An Adaptive Phase III, Multicenter, Randomized, Open-Label, Controlled Study of M7824 (Bintrafusp Alfa) Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer
An Adaptive Phase III, Multicenter, Randomized, Open-Label, Controlled Study of M7824 (Bintrafusp Alfa) Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug
Study Drugs: M7824, Pembrolizumab
Study Phase: Phase 3
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Pemetrexed, Paclitaxel, Gemcitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Enrollment Status: Approved_for_marketing
Publish Date: December 16, 2024
Intervention Type: Drug
A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2 Negative, HR Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated With a Taxane
A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2 Negative, HR Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated With a Taxane
Enrollment Status: Terminated
Publish Date: July 30, 2021
Intervention Type: Drug
Study Drugs: Tesetaxel and Capecitabine, Capecitabine
Study Phase: Phase 3
A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials

187 Total Publications

Tracking and its Potential for Older Adults with Memory Concerns.
Tracking and its Potential for Older Adults with Memory Concerns.
Journal: Proceedings of the SIGCHI conference on human factors in computing systems. CHI Conference
Published: June 26, 2025
Similar Doctors
Expertise in
4
conditions
Jin W. Chang
Holistic Medicine
Expertise in
4
conditions
Jin W. Chang
Holistic Medicine
2270 Venice Blvd, 
Los Angeles, CA 
 (1.7 miles away)
951-616-8780
Languages Spoken:
English

Jin Chang is a Holistic Medicine provider in Los Angeles, California. Mr. Chang is highly rated in 4 conditions, according to our data. His top areas of expertise are Arteriovenous Malformation, Sheehan Syndrome, Thalamotomy, and Gamma Knife Radiosurgery.

Expertise in
3
conditions
Peter R. Galle
Holistic Medicine
Expertise in
3
conditions
Peter R. Galle
Holistic Medicine
566 S San Vicente Blvd, 
Los Angeles, CA 
 (4.9 miles away)
704-577-8657
Languages Spoken:
English

Peter Galle is a Holistic Medicine provider in Los Angeles, California. Mr. Galle is highly rated in 3 conditions, according to our data. His top areas of expertise are Liver Failure, Gallbladder Disease, Endoscopy, and Colonoscopy.

Expertise in
8
conditions
Dr. Hua S. Zhang
Holistic Medicine
Expertise in
8
conditions
Dr. Hua S. Zhang
Holistic Medicine
3011 Glenn Ave, 
Santa Monica, CA 
 (11.1 miles away)
310-422-9768
Languages Spoken:
English

Hua Zhang is a Holistic Medicine provider in Santa Monica, California. Ms. Zhang is highly rated in 8 conditions, according to our data. Her top areas of expertise are Waardenburg Syndrome Type 2, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Periodontitis, Endoscopy, and Nerve Decompression.

Frequently Asked Questions about Eun K. Cho

How do I make an appointment with Eun K. Cho?

You can book an appointment with Eun K. Cho by calling their office at 213-905-0059. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Eun K. Cho a top-rated expert for Endoscopy?

MediFind is an objective health platform that identifies experts based on real-world data. Eun K. Cho is classified as an Experienced expert for Endoscopy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Eun K. Cho specialize in?

While Eun K. Cho is a Holistic Medicine, they have specific expertise in Endoscopy, Colonoscopy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Holistic Medicine.

Does Eun K. Cho participate in research or clinical trials?

Yes. Eun K. Cho has published 187 articles and abstracts on conditions like Endoscopy. You can view a list of Eun K. Cho's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Eun K. Cho accept my insurance?

Eun K. Cho accepts most major insurance plans, including Humana. We recommend calling the office directly at 213-905-0059 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cho's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile